As senior vice president of sales and marketing, Schwartzhoff will be in charge of the company’s growth initiative as well as growing the company’s technology platforms in “soft tissue repair for sports medicine and orthopedic surgery.”
Bret Schwartzhoff Named Maruho Medical SVP Sales & Marketing
1 min read Premium comments
Secondary#bretschwartzhoff#maruhomedical
In Schwartzhoff’s 25-year career he has gained ample senior commercial leadership experience across a range of medical device markets including sports medicine, spine, gastroenterology, and general surgery. For the past year, he has been utilizing that experience to serve companies as a medical device commercial executive/independent consultant.
Prior to joining Maruho Medical, Schwartzhoff spent over six years with Austin, Texas-based Apollo Endosurgery, Inc. as vice president of North America sales and global marketing. Apollo Endosurgery develops therapeutic endoscopy devices used in the treatment of gastrointestinal conditions.
Schwartzhoff joined Apollo Endosurgery from Austin, Texas-based ArthroCare Corporation (acquired by Smith & Nephew, plc) where he was vice president of marketing, sports medicine and vice president sales and marketing, spine. Prior to ArthroCare, he held a number of senior leadership positions with Zimmer, Boston Scientific, and Johnson & Johnson.
Schwartzhoff holds a Master of Business Administration from Wake Forest University. He also holds a Bachelor of Science from Minnesota State University.
Maruho Medical President Chris Runnells expressed excitement about Schwartzhoff joining the company stating, “We are excited to have someone with Bret’s significant commercial leadership background across a wide range of medical device sales and marketing roles join Maruho Medical.”
Runnells continued, “We have a unique opportunity to innovate and launch products with the support of our parent company, Maruho Co., Ltd., and we will leverage our privately-funded positioning to grow through organic development and acquisition, demonstrating a consistent commitment to expanding our product portfolio.”
Maruho Medical is a medical device manufacturer focused on providing technological solutions for soft tissue repair procedures. Its portfolio of orthopedic surgery products includes solutions for several procedures including arthroscopic shoulder, knee, hip, and extremities.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.